NCT00077389 2014-06-24
Intensive Neoadjuvant Chemotherapy in Treating Young Patients Undergoing Surgical Resection for High-Risk Hepatoblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
Clinical Trials
11 trialsNCT00003044 2013-12-19
Chemotherapy in Treating Patients With Liver Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00003296 2013-12-19
Liposomal Doxorubicin in Treating Patients With Liver or Bile Duct Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00079027 2013-12-18
Doxorubicin By Infusion or Chemoembolization in Treating Patients With Advanced Unresectable Hepatocellular Carcinoma (Liver Cancer)
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00027768 2013-09-20
Radioactive Iodine in Treating Patients Who Have Undergone Surgery for Liver Cancer
National Cancer Institute (NCI)
Phase 3 Unknown
NCT00276705 2013-09-17
Combination Chemotherapy and Thalidomide in Treating Younger Patients Undergoing Surgery For Newly Diagnosed Liver Cancer
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00287976 2013-09-17
Irinotecan in Treating Young Patients With Refractory or Recurrent Hepatoblastoma
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00471484 2011-06-22
Combination Chemotherapy and Interferon Alfa-2b in Treating Patients With Nonmetastatic Liver Cancer That Cannot Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT01324076 2011-05-13
Transarterial Chemoembolization Using Doxorubicin Beads With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
National Cancer Institute (NCI)
Phase 3 Unknown
NCT01182272 2010-08-16
Sorafenib Tosylate in Treating Patients With Liver Cancer That Can Be Removed by Surgery
National Cancer Institute (NCI)
Phase 2 Unknown
NCT00006198 2005-06-24
Chronic Thalidomide Administration in Patients Undergoing Chemoembolization for Unresectable Hepatocellular Cancer
National Center for Research Resources (NCRR)
Phase 2 Unknown